Abstract

BackgroundThe two-component NS2B-NS3 proteases of West Nile and dengue viruses are essential for viral replication and established targets for drug development. In all crystal structures of the proteases to date, the NS2B cofactor is located far from the substrate binding site (open conformation) in the absence of inhibitor and lining the substrate binding site (closed conformation) in the presence of an inhibitor.MethodsIn this work, nuclear magnetic resonance (NMR) spectroscopy of isotope and spin-labeled samples of the West Nile virus protease was used to investigate the occurrence of equilibria between open and closed conformations in solution.FindingsIn solution, the closed form of the West Nile virus protease is the predominant conformation irrespective of the presence or absence of inhibitors. Nonetheless, dissociation of the C-terminal part of the NS2B cofactor from the NS3 protease (open conformation) occurs in both the presence and the absence of inhibitors. Low-molecular-weight inhibitors can shift the conformational exchange equilibria so that over 90% of the West Nile virus protease molecules assume the closed conformation. The West Nile virus protease differs from the dengue virus protease, where the open conformation is the predominant form in the absence of inhibitors.ConclusionPartial dissociation of NS2B from NS3 has implications for the way in which the NS3 protease can be positioned with respect to the host cell membrane when NS2B is membrane associated via N- and C-terminal segments present in the polyprotein. In the case of the West Nile virus protease, discovery of low-molecular-weight inhibitors that act by breaking the association of the NS2B cofactor with the NS3 protease is impeded by the natural affinity of the cofactor to the NS3 protease. The same strategy can be more successful in the case of the dengue virus NS2B-NS3 protease.

Highlights

  • West Nile virus (WNV) is a flavivirus related to yellow fever virus, dengue virus, and Japanese encephalitis virus all of which cause human diseases

  • In the case of the West Nile virus protease, discovery of low-molecular-weight inhibitors that act by breaking the association of the NS2B cofactor with the nonstructural protein 3 (NS3) protease is impeded by the natural affinity of the cofactor to the NS3 protease

  • The same strategy can be more successful in the case of the dengue virus NS2B-NS3 protease

Read more

Summary

Introduction

West Nile virus (WNV) is a flavivirus related to yellow fever virus, dengue virus, and Japanese encephalitis virus all of which cause human diseases. The flavivirus RNA genome is translated into a polyprotein comprising of three structural and seven non-structural proteins [1]. The N-terminal part of nonstructural protein 3 (NS3) encodes a serine protease that cleaves the polyprotein into several components. The activity of the NS3 protease (NS3pro) is greatly enhanced by covalent tethering of about 40 residues from the membrane-bound NS2B protein that acts as a co-factor. NS3 is essential for viral replication making it an attractive drug target [2,3,4]. The C-terminal part of NS3 contains a nucleotide triphosphatase, an RNA triphosphatase, and a helicase which have only little influence on the protease activity [5]. The two-component NS2B-NS3 proteases of West Nile and dengue viruses are essential for viral replication and established targets for drug development. In all crystal structures of the proteases to date, the NS2B cofactor is located far from the substrate binding site (open conformation) in the absence of inhibitor and lining the substrate binding site (closed conformation) in the presence of an inhibitor

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call